Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.

Tran, Ha Vu

Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications. [electronic resource] - Cancer genomics & proteomics - 365-378 p. digital

Publication Type: Journal Article

1790-6245

10.21873/cgp.20095 doi


Antineoplastic Agents--adverse effects
Axitinib
Carcinoma, Renal Cell--drug therapy
DNA Copy Number Variations--genetics
Drug Resistance, Neoplasm--genetics
Female
Genome, Human--drug effects
Glioblastoma--drug therapy
Humans
Imidazoles--therapeutic use
Indazoles--therapeutic use
Indoles--therapeutic use
Male
Molecular Targeted Therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Pyrroles--therapeutic use
Sorafenib
Sunitinib
Vascular Endothelial Growth Factor Receptor-1--genetics
Vascular Endothelial Growth Factor Receptor-3--genetics
fms-Like Tyrosine Kinase 3--genetics